Table 4 Reduction of mean pulse pressure values at 12 weeks for each dose of olmesartan and amlodipine FDC
From: Efficacy of olmesartan amlodipine in Colombian hypertensive patients (soat study)
Olmesartan and amlodipine doses | Baseline (mean ± SD) | 12 weeks (mean ± SD) | Difference initial/12 weeks (mean ± SD) | p |
|---|---|---|---|---|
20/5 mg (N = 183 patients) | 63.55 ± 15.57 | 50 ± 11.19 | 13.55 ± 18.84 | <0.001 |
40/5 mg (N = 198 patients) | 65.01 ± 16.92 | 50.12 ± 10.54 | 14.88 ± 21.29 | <0.001 |
40/10 mg (N = 47 patients) | 73.2 ± 17.09 | 51.06 ± 11.21 | 22.13 ± 16.78 | <0.001 |